Secukinumab (AIN457)

secukinumab · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Secukinumab (AIN457), covering 2015-04-10 to 2025-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy and Safety of AIN457/Secukinumab in Patients With Rotator Cuff Tendinopathy [Phase 3]